High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry

in European Journal of Endocrinology
Correspondence should be addressed to E Valassi; Email: EValassi@santpau.cat

(Details of the ERCUSYN Study Group is provided in the Acknowledgements section)

Restricted access

Objective

Patients with Cushing’s syndrome (CS) have increased mortality. The aim of this study was to evaluate the causes and time of death in a large cohort of patients with CS and to establish factors associated with increased mortality.

Methods

In this cohort study, we analyzed 1564 patients included in the European Registry on CS (ERCUSYN); 1045 (67%) had pituitary-dependent CS, 385 (25%) adrenal-dependent CS, 89 (5%) had an ectopic source and 45 (3%) other causes. The median (IQR) overall follow-up time in ERCUSYN was 2.7 (1.2–5.5) years.

Results

Forty-nine patients had died at the time of the analysis; 23 (47%) with pituitary-dependent CS, 6 (12%) with adrenal-dependent CS, 18 (37%) with ectopic CS and two (4%) with CS due to other causes. Of 42 patients whose cause of death was known, 15 (36%) died due to progression of the underlying disease, 13 (31%) due to infections, 7 (17%) due to cardiovascular or cerebrovascular disease and 2 due to pulmonary embolism. The commonest cause of death in patients with pituitary-dependent CS and adrenal-dependent CS were infectious diseases (n = 8) and progression of the underlying tumor (n = 10) in patients with ectopic CS. Patients who had died were older and more often males, and had more frequently muscle weakness, diabetes mellitus and ectopic CS, compared to survivors. Of 49 deceased patients, 22 (45%) died within 90 days from start of treatment and 5 (10%) before any treatment was given. The commonest cause of deaths in these 27 patients were infections (n = 10; 37%). In a regression analysis, age, ectopic CS and active disease were independently associated with overall death before and within 90 days from the start of treatment.

Conclusion

Mortality rate was highest in patients with ectopic CS. Infectious diseases were the commonest cause of death soon after diagnosis, emphasizing the need for careful clinical vigilance at that time, especially in patients presenting with concomitant diabetes mellitus.

 

     European Society of Endocrinology

Related Articles

Article Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 309 309 292
Full Text Views 76 76 70
PDF Downloads 49 49 48

Altmetrics

Figures

  • View in gallery

    Kaplan–Meier plot showing 5-year cumulative survival in patients with pituitary-dependent CS, adrenal-dependent CS and ectopic CS. + denotes censored patients.

References

  • 1

    LindholmJJuulSJorgensenJOAstrupJBjerrePFeldt-RasmussenUHagenCJorgensenJKosteljanetzMKristensenL et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism 2001 117123. (https://doi.org/10.1210/jcem.86.1.7093)

    • Search Google Scholar
    • Export Citation
  • 2

    BollandMJHoldawayIMBerkeleyJELimSDransfieldWJConaglenJVCroxsonMSGambleGDHuntPJToomathRJ. Mortality and morbidity in Cushing’s syndrome in New Zealand. Clinical Endocrinology 2011 436442. (https://doi.org/10.1111/j.1365-2265.2011.04124.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    EtxabeJVazquezJA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clinical Endocrinology 1994 479484. (https://doi.org/10.1111/j.1365-2265.1994.tb02486.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    SwearingenBBillerBMBarkerFG2ndKatznelsonLGrinspoonSKlibanskiAZervasNT. Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine 1999 821824. (https://doi.org/10.7326/0003-4819-130-10-199905180-00015)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    HammerGDTyrrellJBLambornKRAppleburyCBHanneganETBellSRahlRLuAWilsonCB. Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism 2004 63486357. (https://doi.org/10.1210/jc.2003-032180)

    • Search Google Scholar
    • Export Citation
  • 6

    DekkersOMBiermaszNRPereiraAMRoelfsemaFvan AkenMOVoormolenJHCRomijnJA. Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism 2007 976981. (https://doi.org/10.1210/jc.2006-2112)

    • Search Google Scholar
    • Export Citation
  • 7

    DekkersOMHorvath-PuhoEJorgensenJOLCannegieterSCEhrensteinVVandenbrouckeJPPereiraAMSorensenHT. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. Journal of Clinical Endocrinology and Metabolism 2013 22772284. (https://doi.org/10.1210/jc.2012-3582)

    • Search Google Scholar
    • Export Citation
  • 8

    ClaytonRNRaskauskieneDReulenRCJonesPW. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism 2011 632642. (https://doi.org/10.1210/jc.2010-1942)

    • Search Google Scholar
    • Export Citation
  • 9

    ClaytonRNJonesPWReulenRCStewartPMHassan-SmithZKNtaliGKaravitakiNDekkersOMPereiraAMBollandM et al. Mortality in patients with Cushing’s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes and Endocrinology 2016 569576. (https://doi.org/10.1016/S2213-8587(16)30005-5)

    • Search Google Scholar
    • Export Citation
  • 10

    Hassan-SmithZKSherlockMReulenRCArltWAyukJToogoodAACooperMSJohnsonAPStewartPM. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. Journal of Clinical Endocrinology and Metabolism 2012 11941201. (https://doi.org/10.1210/jc.2011-2957)

    • Search Google Scholar
    • Export Citation
  • 11

    LambertJKGoldbergLFayngoldSKostadinovJPostKDGeerEB. Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. Journal of Clinical Endocrinology and Metabolism 2013 10221030. (https://doi.org/10.1210/jc.2012-2893)

    • Search Google Scholar
    • Export Citation
  • 12

    YanevaMKalinovKZacharievaS. Mortality in Cushing’s syndrome: data from 386 patients from a single tertiary referral center. European Journal of Endocrinology 2013 621627. (https://doi.org/10.1530/EJE-13-0320)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    NtaliGAsimakopoulouASiamatrasTKomninosJVassiliadiDTzanelaMTsagarakisSGrossmanABWassJAHKaravitakiN. Mortality in Cushing’s syndrome: systematic analysis of a large series with prolonged follow-up. European Journal of Endocrinology 2013 715723. (https://doi.org/10.1530/EJE-13-0569)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    RagnarssonOOlssonDSPapakokkinouEChantzichristosDDahlqvistPSegerstedtEOlssonTPeterssonMBerinderKBensingS et al. Overall and disease-specific mortality in patients with Cushing’s disease: a Swedish nationwide study. Journal of Clinical Endocrinology and Metabolism 2019 23752384. (https://doi.org/10.1210/jc.2018-02524)

    • Search Google Scholar
    • Export Citation
  • 15

    IliasITorpyDJPacakKMullenNWesleyRANiemanLK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. Journal of Clinical Endocrinology and Metabolism 2005 49554962. (https://doi.org/10.1210/jc.2004-2527)

    • Search Google Scholar
    • Export Citation
  • 16

    ValassiEFeeldersRMaiterDChansonPYanevaMReinckeMKrsekMTothMWebbSMSantosA et al. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing’s disease than patients with cortisol producing adenoma. Data from the ERCUSYN. Clinical Endocrinology 2018 787798. (https://doi.org/10.1111/cen.13600)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    ValassiESantosAYanevaMTothMStrasburgerCJChansonPWassJAHChabreOPfeiferMFeeldersRA et al. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. European Journal of Endocrinology 2011 383392. (https://doi.org/10.1530/EJE-11-0272)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    RaverotGBurmanPMcCormackAHeaneyAPetersennSPopovicVTrouillasJDekkersOM & European Society of Endocrinology. Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European Journal of Endocrinology 2018 G1G24. (https://doi.org/10.1530/EJE-17-0796)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19

    PlotzCMKnowltonAIRaganC. The natural history of Cushing’s syndrome. American Journal of Medicine 1952 597614. (https://doi.org/10.1016/0002-9343(52)90027-2)

    • Search Google Scholar
    • Export Citation
  • 20

    Dirks-NaylorAJGriffithsCL. Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. Journal of Steroid Biochemistry and Molecular Biology 2009 17. (https://doi.org/10.1016/j.jsbmb.2009.05.014)

    • Search Google Scholar
    • Export Citation
  • 21

    AucottJN. Glucocorticoids and infection. Endocrinology and Metabolism Clinics of North America 1994 655670. (https://doi.org/10.1016/S0889-8529(18)30091-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    NiemanLKBillerBMKFindlingJWMuradMHNewell-PriceJSavageMOTabarinA & Endocrine S. Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2015 28072831. (https://doi.org/10.1210/jc.2015-1818)

    • Search Google Scholar
    • Export Citation
  • 23

    AllegranziBBagheri NejadSBCombescureCGraafmansWAttarHDonaldsonLPittetD. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011 228241. (https://doi.org/10.1016/S0140-6736(10)61458-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care 2019 S103S123. (https://doi.org/10.2337/dc19-S010)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25

    CritchleyJACareyIMHarrisTDeWildeSHoskingFJCookDG. Glycemic control and risk of infections among people with Type 1 or Type 2 diabetes in a large primary care cohort study. Diabetes Care 2018 21272135. (https://doi.org/10.2337/dc18-0287)

    • Search Google Scholar
    • Export Citation
  • 26

    LathamRLancasterADCovingtonJFPiroloJSThomasCSJr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infection Control and Hospital Epidemiology 2001 607612. (https://doi.org/10.1086/501830)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    MinettoMALanfrancoFBotterAMottaGMengozziGGiordanoRPicuAGhigoEArvatE. Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing’s disease. European Journal of Endocrinology 2011 985993. (https://doi.org/10.1530/EJE-10-1169)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    StanglMKBockerWChubanovVFerrariUFischerederMGudermannTHesseEMeinkePReinckeMReischN et al. Sarcopenia – endocrinological and neurological aspects. Experimental and Clinical Endocrinology and Diabetes 2019 822. (https://doi.org/10.1055/a-0672-1007)

    • Search Google Scholar
    • Export Citation
  • 29

    SippelRSElarajDMKebebewELindsaySTyrrellJBDuhQY. Waiting for change: symptom resolution after adrenalectomy for Cushing’s syndrome. Surgery 2008 10541061. (https://doi.org/10.1016/j.surg.2008.08.024)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    BerrCMStiegMRDeutschbeinTQuinklerMSchmidmaierROsswaldAReischNRitzelKDimopoulouCFazelJ et al. Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry. European Journal of Endocrinology 2017 737746. (https://doi.org/10.1530/EJE-16-0689)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    RagnarssonOJohannssonG. Cushing’s syndrome: a structured short- and long-term management plan for patients in remission. European Journal of Endocrinology 2013 R139R152. (https://doi.org/10.1530/EJE-13-0534)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    LeongDPTeoKKRangarajanSLopez-JaramilloPAvezumAJrOrlandiniASeronPAhmedSHRosengrenAKelishadiR et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015 266273. (https://doi.org/10.1016/S0140-6736(14)62000-6)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    MoiseyLLMourtzakisMCottonBAPremjiTHeylandDKWadeCEBulgerEKozarRA. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Critical Care 2013 R206. (https://doi.org/10.1186/cc12901)

    • Search Google Scholar
    • Export Citation
  • 34

    Arango-LoperaVEArroyoPGutierrez-RobledoLMPerez-ZepedaMUCesariM. Mortality as an adverse outcome of sarcopenia. Journal of Nutrition Health and Aging 2013 259262. (https://doi.org/10.1007/s12603-012-0434-0)

    • Search Google Scholar
    • Export Citation
  • 35

    EnglesbeMJLeeJSHeKFanLSchaubelDESheetzKHHarbaughCMHolcombeSACampbellDAJrSonnendayCJ et al. Analytic morphomics, core muscle size, and surgical outcomes. Annals of Surgery 2012 255261. (https://doi.org/10.1097/SLA.0b013e31826028b1)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    EnglesbeMJPatelSPHeKLynchRJSchaubelDEHarbaughCHolcombeSAWangSCSegevDLSonnendayCJ. Sarcopenia and mortality after liver transplantation. Journal of the American College of Surgeons 2010 271278. (https://doi.org/10.1016/j.jamcollsurg.2010.03.039)

    • PubMed
    • Search Google Scholar
    • Export Citation

PubMed

Google Scholar